Technology
Technology Across Multiple Clinical Fields
BIOTEGY develops advanced biomaterial technologies and minimally invasive medical solutions across multiple clinical fields, bridging material innovation with real-world clinical needs.
Our technologies support a broad range of medical applications, including orthopedics, dentistry, plastic surgery, ophthalmology, psychiatry and neurology, and minimally invasive surgery.
✓ U.S. FDA 510(k) Clearance (K243951)
TEMP MASTER
TEMP MASTER is a self-curing PMMA-based dental resin designed for temporary crowns and bridges. It offers optimized handling, reliable mechanical strength, excellent polishability, and natural esthetics. The material is suitable for chairside fabrication of provisional restorations and has received FDA 510(k) clearance (K243951), ensuring quality and regulatory compliance.
PMMA BASED DENTAL RESIN PRODUCT
◆ Self-curing temporary bridge resins
◆ Self-curing denture base resins
◆ CAD/CAM milling materials
✓ Taiwan medical device license
BioSight
We created a complete brand identity, intuitive product interface, and high-converting marketing website for an AI startup, delivering a consistent digital experience that strengthened credibility, engagement, and customer acquisition.healing after surgery. TFDA-approved and developed in Taiwan.
◆ Team Taiwan Hemostatic & Anti-Adhesion Powders
◆ PLA/PCL & Gelatin Microspheres for Embolization
◆ PAA-Modified Starch Powders & Sponges for Hemostasis
◆ Biodegradable Materials: New Forms & Applications
✓ Taiwan medical device license
LongLIFT barbed sutures
A next-generation barbed suture developed using an alternative suture material and BIOTEGY’s proprietary barb-making technology. Preliminary in vitro results demonstrated slower degradation and higher pull-out strength compared with conventional polydioxanone sutures.
BIOTEGY developed a proprietary testing platform to quantitatively evaluate pull-out strength across different lifting techniques. By considering suture material, wound size, recovery time, and lifting duration, the platform supports data-driven procedure optimization.
✓ Innovative Material – P(LA/CL)
Spring type sutures
Modifying the current biocompatible polydioxanone to obtain stronger mechanical strength of sutures, and stimulating the proliferation of collagen after spring type sutures after implantation.
Diverse Specifications: Versatile designs and clinical applications.
✓ Approvals in Taiwan & Thailand
PDLLA Dermal filler
A blend of poly-D,L-lactic acid (PDLLA) and carboxymethyl cellulose (CMC) with good biocompatibility, biodegradability, and tissue regeneration potential. Precise tissue implantation stimulates collagen production and fibroblast proliferation, supporting the correction and volumization of nasolabial fold depressions. The product has obtained TFDA Class III medical device marketing approval.
✓ Taiwan medical device license
Plastic Surgery Implant
An ePTFE-based implant designed for plastic surgery applications. Its biocompatible material and implant structure provide a reliable solution for soft-tissue augmentation and contour enhancement.
✓ ISO 13485 QMS Certified
Orthopaedic Anti-adhesive Gel
A tunable medical hydrogel designed for orthopedic applications and adhesion prevention. Its formulation can be tailored to meet specific clinical requirements, providing a versatile platform for the development of advanced anti-adhesive solutions.
✓ Taiwan-Sourced Botanical Ingredients
PuriPosh
PuriPosh combines advanced skincare science with premium botanical ingredients sourced from Taiwan, including indigenous plants selected for their unique skincare benefits. Developed by Biotegy, the collection transforms biomaterial research and scientific expertise into effective daily skincare solutions.